The largest database of trusted experimental protocols

5 protocols using zalcitabine

1

Remdesivir, Zidovudine, and Zalcitabine Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with increasing concentrations of remdesivir (Cayman Chemical or MedChemExpress; purity > 98%; 0.8–400 µM), zidovudine (MedChemExpress, purity 98%; 0.8–1200 µM) or zalcitabine (Selleckchem, purity 100%; 2.4–1200 µM) for 24–120 h. zidovudine and zalcitabine are known for mitotoxic effects during HIV therapy (White 2001 (link)). zidovudine, but not zalcitabine, was shown to change the metabolism of H9c2 cells 6 days after treatment at 50 µM (Lund et al. 2007 (link)). Due to our own observation of zalcitabine reducing mitochondrial DNA in RPTEC/TERT1 cells after long term treatment (Fig. S5e), we compared remdesivir toxicity in cardiac cells or kidney cell lines to the acute toxicity of high doses zidovudine or zalcitabine, respectively. For positive control, cells were treated with high concentrations of dmso (up to 20%) or antimycin A (Sigma, up to 50 µM). ATP levels were determined as indicator of cell vitality of cells cultured to 70–100% confluence in 96-well plates by the CellTiter-Glo® assay (promega) according to manufacturer’s instructions. Luminescence counts acquired by the synergy neo2 multi-mode reader using the software Gen5™ 3.10 (BioTek) were compared between treatment groups. Supernatants were stored to assess lactate concentrations and LDH-activity.
+ Open protocol
+ Expand
2

Mitochondrial Dysfunction Modulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Zalcitabine (S1719), erastin (S7242), sulfasalazine (S1576), IKE (S8877), MitoQ (S8978), bafilomycin A1 (S1413), staurosporine (S1421), and CCCP (S6494) were purchased from Selleck Chemicals. MitoTEMPO (SML0737) was purchased from Sigma-Aldrich. The antibodies to STING1 (13647), TOMM20 (42406), MFN1 (14739), OPA1 (67589), PINK1 (6946), PRKN (4211), ACTB (3700), CALR (12238), and MAP1LC3B (3868) were purchased from Cell Signaling Technology. The antibody to MFN2 (ab205236) was purchased from Abcam. The antibody to mitHsp70 (MA3-028) was purchased from Thermo Fisher Scientific.
+ Open protocol
+ Expand
3

Compound Solubilization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Etravirine, zalcitabine, tanespimycin, wortmannin, and calcium D-pantothenate were all purchased from Selleck (Shanghai, China) and ellipticine was purchased from MedChemExpress (MCE, Shanghai, China). All of these powders were dissolved in the appropriate solvent according to the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Evaluating Anti-HIV Drug Efficacy in Patient Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma samples from HIV-1 infected patients were provided by the center of disease prevention and control (CDC), Shenzhen, China. All patients had been treated with antiviral drugs in the past years. All participating patients signed an informed consent for sample collection and testing. This study was approved by the Medical Ethics Committee of Southern Medical University (permit numbers: NFYY-2008-045), Guangzhou, China. All experiments were carried out in accordance with the approved guidelines.
Twelve HIV-1 inhibitors were used in this study, including six nucleoside reverse-transcriptase inhibitors (NRTIs): Didanosine (DDI), Stavudine (D4T), Zidovudine (AZT), Zalcitabine (DDC), Emtricitabine (FTC), Abacavir Sulfate (ABC), four non-nucleoside reverse transcriptase inhibitors (NNRTIs): Nevirapine (NVP), Etravirine (ETR), Dapivirine (DPV), Rilpivirine (RPV), and two protease inhibitors (PIs): Nelfinavir (NFV) and Lopinavir (LPV), which were purchased commercially from Selleckchem (Shanghai, China).
+ Open protocol
+ Expand
5

Dexrazoxane-Protein Interaction Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dexrazoxane (#S5651), trimethoprim (#S3129), zalcitabine (#S1719), emtricitabine (#S1704), lamivudine (#S1706), and nitisinone (#S5325) were acquired from Selleckchem. Drugs-conjugated Sepharose 4B beads were prepared per GE Healthcare's manufacturer's guidelines (#17-0430-01). In total, 1 mg total cell lysates or 500 ng recombinant SDCBP proteins were incubated with control Sepharose 4B beads or Dexrazoxane conjugated Sepharose 4B beads in reaction buffer overnight at 4 °C. Western blotting was used to detect the presence of SDCBP protein attached to the beads after they were buffer-washed five times.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!